FIRSTFARMS A/S financials
FIRSTFARMS A/S
2138007DFVFLUCCSX925 | Line item | 2026 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|
| Income statement | |||
| Revenue | DKK 199.6M | DKK 379.2M | DKK 192.2M |
| Other income | DKK 4.0M | DKK 39.3M | DKK 35.3M |
| Employee benefits expense | DKK 56.8M | DKK 113.7M | DKK 58.1M |
| Raw materials & consumables used | DKK 147.7M | DKK 224.2M | DKK 106.9M |
| Operating profit (EBIT) | -DKK 32.5M | DKK 12.7M | DKK 22.1M |
| Finance costs | DKK 19.2M | DKK 35.8M | DKK 18.2M |
| Profit before tax | -DKK 50.2M | -DKK 18.7M | DKK 6.5M |
| Income tax expense | -DKK 2.0M | DKK 1.9M | DKK 1.8M |
| Profit for the year | -DKK 48.2M | -DKK 20.6M | DKK 4.8M |
| Total comprehensive income | -DKK 40.5M | -DKK 13.6M | DKK 4.0M |
| Per share | |||
| Basic EPS | DKK -3.94 | DKK -1.76 | DKK 0.39 |
| Diluted EPS | DKK -3.94 | DKK -1.76 | DKK 0.39 |
| Free cash flow / share | DKK -3.38 | — | DKK -6.95 |
| Cash flow statement | |||
| Cash generated from operations | DKK 9.5M | — | DKK 12.9M |
| Net cash from operating activities | -DKK 11.7M | — | DKK 1.6M |
| Income taxes paid | DKK 3.5M | — | -DKK 4.3M |
| Net cash from investing activities | -DKK 52.8M | — | -DKK 86.2M |
| Purchase of PP&E (capex) | DKK 29.7M | — | DKK 86.4M |
| Net cash from financing activities | DKK 67.9M | — | DKK 18.6M |
| Dividends paid | DKK 0 | — | DKK 0 |
| Proceeds from borrowings | DKK 41.1M | — | DKK 25.7M |
| Repayments of borrowings | DKK 24.4M | — | DKK 6.8M |
| Net change in cash | DKK 3.4M | — | -DKK 66.0M |
| Balance sheet | |||
| Total assets | DKK 1.82B | DKK 1.74B | DKK 1.73B |
| Non-current assets | DKK 1.45B | DKK 1.38B | DKK 1.30B |
| Intangible assets & goodwill | DKK 16.1M | DKK 16.1M | DKK 16.1M |
| Current assets | DKK 371.1M | DKK 367.0M | DKK 434.2M |
| Inventories | DKK 92.2M | DKK 157.0M | DKK 61.6M |
| Trade & other receivables | DKK 29.6M | DKK 23.4M | DKK 25.2M |
| Cash & equivalents | DKK 15.6M | DKK 12.1M | DKK 71.7M |
| Total equity | DKK 860.1M | DKK 899.3M | DKK 915.7M |
| — attributable to owners | DKK 858.4M | DKK 898.5M | DKK 915.6M |
| Non-controlling interests | DKK 1.7M | DKK 720.0K | DKK 93.0K |
| Non-current liabilities | DKK 710.6M | DKK 675.4M | DKK 623.1M |
| Long-term borrowings | DKK 544.1M | DKK 517.2M | DKK 508.0M |
| Current liabilities | DKK 249.3M | DKK 170.2M | DKK 193.3M |
| Trade & other payables | DKK 81.1M | DKK 57.2M | DKK 74.2M |
| Deferred tax liabilities | DKK 49.7M | DKK 38.0M | DKK 43.9M |
| Derived metrics | |||
| Free cash flow | -DKK 41.4M | — | -DKK 84.8M |
| Operating margin | -16.3% | 3.3% | 11.5% |
| Net margin | -24.2% | -5.4% | 2.5% |
| Return on equity | -5.6% | -2.3% | 0.5% |
| Cash conversion ratio | 0.24× | — | 0.34× |
| Capex coverage | -0.39× | — | 0.02× |
| Other reported items | |||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 35.0M | — | DKK 32.3M |
| Adjustments For Finance Costs | DKK 19.2M | — | DKK 18.2M |
| Adjustments For Finance Income | DKK 1.6M | — | DKK 2.6M |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | DKK 2.8M | — | DKK 7.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -DKK 2.6M | — | DKK 0 |
| Adjustments For Sharebased Payments | DKK 0 | — | DKK 550.0K |
| Buildings | DKK 461.6M | DKK 450.3M | DKK 406.8M |
| Cash and Cash Equivalents In Subsidiary Or Businesses Acquired Or Disposed2013 | DKK 36.0K | — | DKK 0 |
| Cash Flows From Used In Increase Decrease In Current Borrowings | DKK 51.2M | — | DKK 0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | -DKK 2.9M | — | DKK 47.8M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | DKK 30.3M | — | DKK 0 |
| Changes In Equity | -DKK 40.1M | — | DKK 96.5M |
| Construction In Progress | DKK 52.2M | DKK 57.4M | DKK 88.7M |
| Current Biological Assets | DKK 184.2M | DKK 128.8M | DKK 217.7M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | DKK 163.5M | DKK 108.0M | DKK 113.8M |
| Current Government Grants | DKK 4.7M | DKK 4.5M | DKK 5.3M |
| Current Prepayments and Current Accrued Income Including Current Contract Assets | DKK 6.7M | DKK 6.9M | DKK 5.7M |
| Current Tax Assets Current | DKK 8.6M | DKK 5.9M | DKK 4.4M |
| Current Tax Liabilities Current | DKK 13.0K | DKK 495.0K | DKK 0 |
| Deferred Tax Assets | DKK 25.8M | DKK 17.2M | DKK 19.7M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | DKK 35.0M | DKK 66.5M | DKK 32.3M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | DKK 129.0K | — | DKK 0 |
| Equity and Liabilities | DKK 1.82B | DKK 1.74B | DKK 1.73B |
| Finance Income | DKK 1.6M | DKK 4.5M | DKK 2.6M |
| Gains Losses On Cash Flow Hedges Before Tax | DKK 0 | DKK 0 | DKK 0 |
| Gains Losses On Fair Value Adjustment Biological Assets | DKK 2.8M | -DKK 6.2M | DKK 7.2M |
| Income Tax Relating To Components of Other Comprehensive Income | DKK 0 | DKK 0 | DKK 0 |
| Increase Decrease In Working Capital | -DKK 12.4M | — | DKK 34.9M |
| Increase Decrease Through Conversion of Convertible Instruments | DKK 0 | — | DKK 92.2M |
| Increase Decrease Through Exercise of Warrants Equity | DKK 0 | — | DKK 0 |
| Interest Paid Classified As Operating Activities | DKK 19.2M | — | DKK 18.2M |
| Interest Received Classified As Operating Activities | DKK 1.6M | — | DKK 2.6M |
| Issue of Equity | DKK 0 | — | DKK 0 |
| Issued Capital | DKK 122.5M | DKK 122.5M | DKK 122.5M |
| Land | DKK 494.5M | DKK 453.1M | DKK 439.1M |
| Liabilities | DKK 959.9M | DKK 845.5M | DKK 816.4M |
| Noncurrent Biological Assets | DKK 65.4M | DKK 56.7M | DKK 34.0M |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | DKK 45.2M | DKK 45.1M | DKK 45.1M |
| Noncurrent Government Grants | DKK 114.4M | DKK 116.9M | DKK 70.5M |
| Other Comprehensive Income | DKK 7.7M | DKK 7.0M | -DKK 725.0K |
| Other Comprehensive Income Attributable To Noncontrolling Interests | -DKK 949.0K | -DKK 660.0K | DKK 33.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | DKK 8.6M | DKK 7.7M | -DKK 758.0K |
| Other Current Receivables | DKK 34.2M | DKK 32.9M | DKK 47.9M |
| Other Noncurrent Assets | DKK 71.0M | DKK 62.3M | DKK 64.7M |
| Other Noncurrent Payables | DKK 2.3M | DKK 3.3M | DKK 691.0K |
| Other Property Plant and Equipment | DKK 18.1M | DKK 12.6M | DKK 12.6M |
| Payments To Acquire Or Redeem Entitys Shares | DKK 0 | — | DKK 343.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | DKK 7.2M | — | DKK 242.0K |
| Property Plant and Equipment Including Rightofuse Assets | DKK 1.30B | DKK 1.24B | DKK 1.18B |
| Purchase of Treasury Shares | DKK 0 | — | DKK 343.0K |
| Reserve of Cash Flow Hedges | DKK 0 | DKK 0 | DKK 0 |
| Reserve of Exchange Differences On Translation | -DKK 32.6M | -DKK 41.2M | -DKK 49.6M |
| Retained Earnings | DKK 768.6M | DKK 817.3M | DKK 842.7M |
| Revenue and Operating Income | DKK 240.3M | DKK 499.3M | DKK 262.7M |
| Revenue From Government Grants | DKK 33.9M | DKK 86.9M | DKK 28.0M |
Every line item above is a fact tagged in FIRSTFARMS A/S's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (DKK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.